260 related articles for article (PubMed ID: 16305397)
21. Cyclodextrins in pharmaceutical formulations II: solubilization, binding constant, and complexation efficiency.
Jambhekar SS; Breen P
Drug Discov Today; 2016 Feb; 21(2):363-8. PubMed ID: 26687191
[TBL] [Abstract][Full Text] [Related]
22. Bioavailability and anticataract effects of a topical ocular drug delivery system containing disulfiram and hydroxypropyl-beta-cyclodextrin on selenite-treated rats.
Wang S; Li D; Ito Y; Nabekura T; Wang S; Zhang J; Wu C
Curr Eye Res; 2004 Jul; 29(1):51-8. PubMed ID: 15370367
[TBL] [Abstract][Full Text] [Related]
23. Amphiphilic cyclodextrin nanoparticles.
Varan G; Varan C; Erdoğar N; Hıncal AA; Bilensoy E
Int J Pharm; 2017 Oct; 531(2):457-469. PubMed ID: 28596142
[TBL] [Abstract][Full Text] [Related]
24. Cyclodextrins and Drug Membrane Permeation: Thermodynamic Considerations.
Sripetch S; Prajapati M; Loftsson T
J Pharm Sci; 2022 Sep; 111(9):2571-2580. PubMed ID: 35487262
[TBL] [Abstract][Full Text] [Related]
25. Inclusion complexation of lorazepam with different cyclodextrins suitable for parenteral use.
Holvoet C; Vander Heyden Y; Plaizier-Vercammen J
Drug Dev Ind Pharm; 2005 Jul; 31(6):567-75. PubMed ID: 16109630
[TBL] [Abstract][Full Text] [Related]
26. Daidzein/cyclodextrin/hydrophilic polymer ternary systems.
Borghetti GS; Pinto AP; Lula IS; Sinisterra RD; Teixeira HF; Bassani VL
Drug Dev Ind Pharm; 2011 Aug; 37(8):886-93. PubMed ID: 21247375
[TBL] [Abstract][Full Text] [Related]
27. Intracorneal melatonin delivery using 2-hydroxypropyl-β-cyclodextrin ophthalmic solution for granular corneal dystrophy type 2.
Ahn JH; Kim HD; Abuzar SM; Lee JY; Jin SE; Kim EK; Hwang SJ
Int J Pharm; 2017 Aug; 529(1-2):608-616. PubMed ID: 28694094
[TBL] [Abstract][Full Text] [Related]
28. Entrapment of cyclodextrin-drug complexes into liposomes: potential advantages in drug delivery.
McCormack B; Gregoriadis G
J Drug Target; 1994; 2(5):449-54. PubMed ID: 7704490
[TBL] [Abstract][Full Text] [Related]
29. Cyclodextrin solubilization of the antibacterial agents triclosan and triclocarban: formation of aggregates and higher-order complexes.
Duan MS; Zhao N; Ossurardóttir IB; Thorsteinsson T; Loftsson T
Int J Pharm; 2005 Jun; 297(1-2):213-22. PubMed ID: 15885935
[TBL] [Abstract][Full Text] [Related]
30. Hydrophilic and hydrophobic cyclodextrins in a new sustained release oral formulation of nicardipine: in vitro evaluation and bioavailability studies in rabbits.
Fernandes CM; Ramos P; Falcão AC; Veiga FJ
J Control Release; 2003 Feb; 88(1):127-34. PubMed ID: 12586510
[TBL] [Abstract][Full Text] [Related]
31. New prostaglandin analog formulation for glaucoma treatment containing cyclodextrins for improved stability, solubility and ocular tolerance.
Rodriguez-Aller M; Guinchard S; Guillarme D; Pupier M; Jeannerat D; Rivara-Minten E; Veuthey JL; Gurny R
Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):203-14. PubMed ID: 25960331
[TBL] [Abstract][Full Text] [Related]
32. Drug permeation through biomembranes: cyclodextrins and the unstirred water layer.
Loftsson T
Pharmazie; 2012 May; 67(5):363-70. PubMed ID: 22764564
[TBL] [Abstract][Full Text] [Related]
33. Self-assembly of cyclodextrin complexes: detection, obstacles and benefits.
Muankaew C; Saokham P; Jansook P; Loftsson T
Pharmazie; 2020 Jul; 75(7):307-312. PubMed ID: 32635971
[TBL] [Abstract][Full Text] [Related]
34. Effect of water-soluble polymers on naproxen complexation with natural and chemically modified beta-cyclodextrins.
Faucci MT; Mura P
Drug Dev Ind Pharm; 2001 Oct; 27(9):909-17. PubMed ID: 11763468
[TBL] [Abstract][Full Text] [Related]
35. Co-administration of a water-soluble polymer increases the usefulness of cyclodextrins in solid oral dosage forms.
Savolainen J; Järvinen K; Taipale H; Jarho P; Loftsson T; Järvinen T
Pharm Res; 1998 Nov; 15(11):1696-701. PubMed ID: 9833990
[TBL] [Abstract][Full Text] [Related]
36. Liposomes incorporating cyclodextrin-drug inclusion complexes: Current state of knowledge.
Gharib R; Greige-Gerges H; Fourmentin S; Charcosset C; Auezova L
Carbohydr Polym; 2015 Sep; 129():175-86. PubMed ID: 26050903
[TBL] [Abstract][Full Text] [Related]
37. Intraocular distribution of topically applied hydrophilic and lipophilic substances in rat eyes.
Abdul Nasir NA; Agarwal P; Agarwal R; Iezhitsa I; Alyautdin R; Nukolova NN; Chekhonin VP; Mohd Ismail N
Drug Deliv; 2016 Oct; 23(8):2765-2771. PubMed ID: 26289215
[TBL] [Abstract][Full Text] [Related]
38. Cyclodextrin solubilization of ETH-615, a zwitterionic drug.
Loftsson T; Petersen DS
Drug Dev Ind Pharm; 1998 Apr; 24(4):365-70. PubMed ID: 9876597
[TBL] [Abstract][Full Text] [Related]
39. Characteristic of Cyclodextrins: Their Role and Use in the Pharmaceutical Technology.
Lachowicz M; Stańczak A; Kołodziejczyk M
Curr Drug Targets; 2020; 21(14):1495-1510. PubMed ID: 32538725
[TBL] [Abstract][Full Text] [Related]
40. Enhancement and inhibition effects on the corneal permeability of timolol maleate: Polymers, cyclodextrins and chelating agents.
Rodríguez I; Vázquez JA; Pastrana L; Khutoryanskiy VV
Int J Pharm; 2017 Aug; 529(1-2):168-177. PubMed ID: 28652172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
